|
| Author and year | Study design | Search date | Objective | Number of studies included | Design and number of included studies | Participants (n) |
|
| Yu et al., 2020 [28] | SRM | January 2019 | To investigate the effect of non-invasive brain stimulation for SCI | 11 | RCT: 11 | 274 |
| Yang et al., 2020 [29] | SR | June 2019 | To explore the effect of rTMS on different types of pain | 106 | RCT: 69; OLT: 16; CR: 21 | 3,264 |
| Xu et al., 2020 [30] | SR | August 2020 | To assess the efficacy and safety of non-pharmacological therapies for CPSP | 11 | RCT: 11 | 210 |
| Moisset et al., 2020 [31] | SRM | July 2020 | To investigate the efficacy of neurostimulation techniques in migraine | 38 | RCT: 38 | 2,899 |
| Moisset et al., 2020 [32] | SR | August 2019 | To propose all the alternative treatment options for NP | 131 | RCT: 131 | 15,776 |
| Liampas et al., 2020 [33] | SRM | November 2019 | To describe the prevalence and characteristics of CPSP and investigate the relevant management methods | 69 | NR | NA |
| Gatzinsky et al., 2020 [22] | SR | June 2019 | To review the efficacy and safety of rTMS on M1 | 32 | RCT: 24; CS: 8 | 682 (RCT) |
| Aamir et al., 2020 [34] | SR | June 2019 | To evaluate the effect of rTMSfor peripheral NP | 12 | RCT: 5; CS: 2; CR: 5 | 188 |
| Stilling et al., 2020 [35] | SR | September 2018 | To review the use of TMS and tDCS for specific headache disorders | 34 | Randomized trials: 20; NRC/prospective cohort/OLT: 14 | 1,787 |
| Ramger et al., 2019 [26] | SR | 2018 | To evaluate the efficacy of rTMS and tDCS for CPSP | 6 | RCT: 1; prospective cohort: 1; CS: 2; cross-over: 2 | 109 |
| Hamid et al., 2019 [36] | SR | 2018 | To explore the effect of rTMS on chronic refractory pain, especially in adults with central NP | 12 | RCT: 12 | 350 |
| Feng et al., 2019 [37] | SRM | September 2018 | To evaluate the efficacy of rTMS and tDCS for migraine | 9 | RCT: 9 | 276 |
| O'Connell et al., 2018 [23] | SRM | October 2017 | To assess the efficacy of non-invasive cortical stimulation techniques on chronic pain | 94 | RCT: 94 | 2,983 |
| Herrero babiloni et al., 2018 [27] | SR | NR | To explore the effect of TMS and tDCS for chronic OFP | 14 | RCT: 14 | 228 |
| Lan et al., 2017 [38] | SRM | April 2017 | To explore the efficacy of TMS for migraine | 5 | RCT: 5 | 313 |
| Kumru et al., 2017 [39] | SR | August 2015 | To assess the role of rTMS or peripheral magnetic stimulation for NP | 39 | NR | 892 |
| Goudra et al., 2017 [40] | SRM | NR | To evaluate the effect of rTMS for chronic pain | 9 | RCT: 6; prospective observational: 3 | 183 |
| Shirahige et al., 2016 | SRM | November 11, 2015, to January 15, 2016 | To assess the effect of NIBS on migraine patients | 8 | RCT: 8 | 296 |
| Cragg et al., 2016 [42] | SRM | May 2015 | To explore the predictors of placebo responses in central NP clinical trials | 39 | RCT: 39 | 1,153 |
| Chen et al., 2016 [43] | SR | September 2015 | To evaluate the antalgic effects of non-invasive physical modalities on CPSP | 16 | NA | 184 |
| Jin et al., 2015 [44] | SRM | December 2014 | To evaluate the optimal parameters of rTMS for NP | 25 | RCT: 20; self-controlled: 5 | 589 |
| Galhardoni et al., 2015 [45] | SR | 2014 | To review the studies on the analgesic effects of rTMS in chronic pain | 33 | RCT: 33 | 842 |
| Leung et al., 2009 [46] | SRM | August 2007 | To evaluate the overall effect of rTMS for NP and evaluate the effect of treatment parameters. | 5 | RCT: 5 | 149 |
|
